COMPANY
Our Purpose
Creating a Pain Free World
TOP MESSAGE
AIMS is a leading-edge IT company with a mission to “create and extend the personal wellness index life span.
I had supported women’s advancement in society at my previous job.
We are also working on AIMS, starting with stress reduction for women and women raising children who will nurture the generation that will lead the future generation, and we are transmitting the concept of the personal wellness index from Fukushima, which has overcome the nuclear power plant and earthquake disaster, to all of Japan and the world.
Stress is felt differently by each person. It is difficult to eliminate stress itself.
That is why AIMS uses cutting-edge AI technology to analyze each person’s personal wellness index and promote behavioral change, thereby providing society with know-how, products, and services that enable people to live healthy and happy lives while enjoying their lives.
With the financial crisis caused by the Lehman Shock, the advance of virtual currencies, and the Corona disaster, the values of people not only in Japan but around the world are now undergoing a major change.
AIMS provides Health & Happiness as a service (HaaS), a social contribution that respects the wellbeing of each individual.
Our company alone cannot change the social landscape.
The most important indicator in our company is a culture that allows us to work hand in hand with many people as a beloved partner.
Hiromi Kawamata AIMS Inc.
COMPANY PROFILE
Providing a world of “health” by making full use of cutting-edge technology.
We are working on AI development every day with the goal of providing the true “health” that people demand.
We believe that if we can make the full use of cutting-edge technology we will be able to create new solutions for wellbeing that have never been seen before. It is important to create services that consider the global environment. Also, we should always keep in mind the user’s point of view and to pursue solutions that are easy to fit into our life.
| Company name | AIMS Inc. |
|---|---|
| Representative | CEO Hiromi Kawamata |
| Location | Main office
Development base |
| Capital | 63,624,000 yen (including capital reserve) |
| Established | July 11, 2019 (first year of Reiwa) |
| Fiscal Month | June |
| Employees | 20 people (including those scheduled to be hired in 2022) |
| Business content |
|
| Affiliated company |
|
HISTORY
2019
- JulyEstablished on July 11, 2019
- AugustAI engine original development announcement
- OctoberExhibited at Japan Healthcare Venture Summit sponsored by Ministry of Health, Labor and Welfare
Participated in the International Summit as a representative of AIMS at DELL DWEN - NovemberEstablished a business alliance with the Nanohana Clinic Group
- DecemberStarted joint development of skin AI with Chimerabo Co., Ltd.
2020
- AprilParticipation in the accelerator program WOMB
- JuneStarted development of artificial intelligence AiSkin that visualizes health condition from skin
- OctoberAiSkin announced at DWEN
- DecemberAiSkin monitor benefits start
2021
- JanuaryAiSkin β version completed by applying the algorithm of Rape Clinic Yukako Sugawara
- FebruaryEstablished an IP strategy partner with Sosei International Patent Attorney Office
- AprilEstablished Fukushima branch in Tamura city and started joint business toward comprehensive cooperation agreement
- JulyReiwa 3rd year regional reconstruction, practical development, subsidy adoption, project adoption
- SeptemberStarted planning the construction of a Wellness Hub at the development base in Tamura City as a Fukushima reconstruction project.
- OctoberEstablished SDGs business partnership with Flexas Z Co., Ltd.
2022
- JanuaryCompletion of AiLive α version and launch of AI engine of Vnext
Launch of HR + app with original content
With the support of the Reconstruction Agency, a demonstration experiment and publication of a bulletin in Tamura City - MarchMedia appearance of “Ai Live” demonstration experiment (Fukushima Broadcasting, Fukushima Shimbun)
Established Limited Liability Partnership (LLP) Peace & Highlight by Investors - AprilCEO Hiromi Kawamata selected as 13th Softbank Academia Student
AiLive demonstration experiment started at a company - JuneConcluded a business transfer alliance with Shinkeiikagaku Research Institute
- AugustAdopted as a startup company for the global open innovation program “Well-BeingX”
Women’s volleyball team, DENSO AIRYBEES, starts demonstration experiment of AiLive - OctoberJunichiro Kojou appeared in the media program “NHK Culture”: The newest medical treatment “Medicine x Engineering” – Neurotherapy Synaptic Therapy
Exhibited at Medical Creation Fukushima 2022 - DecemberDemonstration experiment again in Tamura City and publication of the journal
Presentation at HGC Symposium
Demonstration experiment at a company in Fukushima Prefecture
2023
- JanuaryCEO Hiromi Kawamata took the platform at Morning Pitch “January 19th, the 440th Fukushima Innovation Collaboration Special”
- MarchCEO Hiromi Kawamata took the platform at “Founders Night Marunouchivol.48 Speaker”
Demonstration experiment at “Spa Resort Hawaiians” by JJoban Kosan Co., Ltd.
TUS holdings business visit from Tsinghua University at our Ochanomizu-office - AprilOpened “Tamura Mirai Medical Promotion Center” in Tamura City, Fukushima Prefecture
Mr. Takeya, Vice Minister of Reconstruction visited “MPC”
ORGANIZATION
In order to access quality human resources and create a sustainable working style AIMS is setting up projects with management, Fukushima staff, and LLP members from numerous partners and investors
Leadership
Hiromi has been closely involved with Silicon Valley startups which helped her to start an AI business with Professor Muto. In her early twenties, she launched Lindoors Co., Ltd., an innovative advertising agency centered on housewives working from home. She is the representative of Dell International Women Business Council Japan. She has served as an advisor for women’s employment support at Google Japan and as an editor-in-chief of Japan’s largest daily life weekly magazine. Hiromi has been a student at Softbank Academia, a prestigious management and leadership development program run by Sofbank.Hiromi Kawamata
Representative Director and Chief Executive Officer
2008 Keio University Leading Research Center Table COE Researcher. Dr Kojou received an award for collaboration in co-study between MIT and Stanford University.
In 2021, Dr Kojou served as representative of the Institute of Neuromedical Sciences. In the same year he started practicing “synaptic therapy” to treat nerve pain by hand. In 2022, he became the director of the Japan Neuromedical Engineering Institute. In June, 2022 Dr Kojou joined AIMS Co as a board member.
Junichiro Kojou
Senior Managing Chief Health Officer
A unique practitioner representing the industry. He is active as a judo rehabilitator and acupuncturist. He broke many records in the practitioner industry. The high level of his technique is introduced on TV and books, and many practitioners from all over the country gather to learn the technique from him. The ability to teach technique to other students is unmatched in the industry, and students continue to produce amazing results in highly reproducible workshops. He has earned tremendous trust from many top athletes.Nobuhiko Tanaka
Managing Chief Learning Officer